Clinical trial registration at tobacco control

Tobacco Control

Volumn 15, Issue 6, 2006, Pages 417-418

  Bero, L A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845568393     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.2006.018887     Document Type: Editorial

References (24)

1. Bero LA, Jadad AR. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med 1997;127:37-42.
2. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997;126:376-80.
3. Stern J, Simes R. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997;315:640-5.
4. Chalmers I. Underreporting research is scientific misconduct. JAMA 1990;263:1405-8.
5. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-9.
6. Dickersin K, Chan S, Chalmers TC, et al. Publication bias and clinical trials. Control Clin Trials 1987;8:343-53.
7. Dickersin K, Min Y-I, Meinert C. Factors influencing publication of research results. JAMA 1992;267:374-8.
8. Simes R. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986;4:1529-41.
9. Sterling T. Publication decisions and their possible effects on inferences drawn from tests of significance - or vice versa. J Am Stat Assoc 1959;54:30-4.
10. Ioannidis JP. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998;279:281-6.
11. Misakian AL, Bero LA. Publication bias and research on passive smoking: comparison of published and unpublished studies. JAMA 1998;280:250-3.
12. Ioannidis JP, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998;279:1089-93.
13. Easterbrook P, Berlin J, Gopalan R, et al. Publication bias in clinical research. Lancet 1991;337:867-72.
14. Lee K, Holroyd-Leduc J, Bachetti P, et al. Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major medical journals. Med J Aust 2006;184:621-6.
15. Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 2005;330:753.
16. Chan AW, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65.
17. Chan AW, Krleza-Jeric K, Schmid I, et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171:735-40.
18. Melander H, Ahlqvist-Rastad J, Meijer G, et al. Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003;326:1171-3.
19. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5.
20. Hemminki E. Study of information submitted by drug companies to licensing authorities. BMJ 1980;280:833-6.
21. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
22. Bero L. Tobacco industry manipulation of research. Public Health Rep 2005;120:200-8.
23. Steinman M, Bero L, Chren M-M, et al. The promotion of Gabapentin: an analysis of internal industry documents. Ann Intern Med 2006;145:284-93.
24. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004;292:1363-4.